BIOMARIN PHARMACEUTICAL INC: accounts_receivable
| Value | {"amount": 633704000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2023-12-31) |
| Status | current |
| Entity | BIOMARIN PHARMACEUTICAL INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:17:13.171852+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/81fc603d-75b9-453a-8343-b448bb6d7c14
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001048477-24-000016Retrieved: 2026-08-19T10:17:13.171852+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001048477/accounts-receivable/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/81fc603d-75b9-453a-8343-b448bb6d7c14
History
- no predecessors — first report